A Menarini voluntary admission: late Disclosure UK upload of 2016 R&D clinical trial payment (AUTH/2975/9/17)

📅 2017 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2975/9/17
CompanyA Menarini
IssueLate disclosure of research and development (R&D) clinical trial payment(s) to a UK organisation
Applicable Code year2016
Initial disclosure submission date29 March 2017
Disclosure deadline30 June 2017
Late upload date21 August 2017
Portal integration confirmation6 September 2017
Complaint received30 August 2017
Voluntary admission received31 August 2017
Completed16 January 2018
Breach clause(s)Clause 24.4
SanctionsUndertaking received
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A Menarini made its initial, timely Disclosure UK submission for 2016 transfers of value on 29 March 2017.
  • After that submission, it received additional information from corporate/R&D colleagues about clinical trial (R&D) payments made to a UK organisation during 2016.
  • The additional R&D payment data was uploaded to the ABPI Transfer of Value Portal on 21 August 2017 (integrated on the portal on 6 September 2017).
  • The disclosure deadline for 2016 transfers of value was 30 June 2017 (first six months after year-end).
  • Under Paragraph 5.6 of the Constitution and Procedure, the PMCPA Director treated the voluntary admission as a complaint.
⚖️

Outcome

  • Breach ruled for late disclosure.
  • The Panel found the disclosure deadline in Clause 24.4 had not been met because the data was not published within the first six months after the end of the calendar year in which the transfers of value were made.
  • The Panel disagreed with the company’s interpretation that “any submission of additional data after 30 June” would automatically be a breach; the key point was whether the data was published by the deadline (it was not).
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training